1[1]Murabito JM,D'Agostino RB,Silbershatz H,et al.Intermittent clau-dication:a risk profile from the Framingham Heart Study[J].Circulation,1997,96(1):44-49.
2[2]Hiatt WR.Medical treatment of peripheral arterial disease and claudi-cation[J].N Engl J Med,2001,344(21):1608-1621.
3[3]Lavery L,Gazewood JD.Assessing the feet in patients with diabetes[J].J Fam Pract,2000,49(11 suppl):9-16.
4[4]Elhadd TA,Robb R,Jung RT,et al.Pilot study of prevalence of as-ymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic[J].Practical Diabetes Int,1999,16:163-166.
6[6]Kallio M,Forsblom C,Groop PH,et al.Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years[J].Diabetes Care,2003,26(4):1241-1245.
7[7]Casadei A,Floreani M,Fanolla A,et al.Peripheral arterial disease in a population of type 2 diabetic patients:its correlation with diabetic microangiopathy and laboratory parameters[J].Minerva-Cardioangiol,2003,51(3):323-328.
8[8]Peters EJ,Lavery LA.Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot[J].Diabetes Care,2001,24(8):1442-1447.
9[9]The Global Lower Extremity Amputation Study Group:Epidemiology of lower extremity amputation in centers in Europe,North America and East Asia[J].Br J Surg,2000,87(3):328-337.
10[10]Jude EB,Oyibo SO,Chalmers N,et al.Peripheral arterial disease in di-abetic and nondiabetic patients:a comparison of severity and outcome[J].Diabetes Care,2001,24(8):1433-1437.
